Stock Analysis Report

Header cover image

Executive Summary

Medicon Hellas S.A. operates in the diagnostics industry.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

Share Price & News

How has Medicon Hellas's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: MEDIC's share price has been volatile over the past 3 months.

Market Performance

7 Day Return




GR Medical Equipment


GR Market

1 Year Return




GR Medical Equipment


GR Market

Return vs Industry: MEDIC underperformed the Greek Medical Equipment industry which returned 21.8% over the past year.

Return vs Market: MEDIC exceeded the Greek Market which returned -13.2% over the past year.

Shareholder returns

7 Day1.5%5.8%1.6%
30 Day-1.0%11.0%2.5%
90 Day-18.0%9.2%-22.4%
1 Year14.3%14.3%25.8%24.7%-12.1%-15.7%
3 Year150.0%150.0%60.2%53.1%-10.1%-18.7%
5 Year589.7%589.7%129.5%110.1%-70.5%-71.7%

Price Volatility Vs. Market

How volatile is Medicon Hellas's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is Medicon Hellas undervalued compared to its fair value and its price relative to the market?


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: MEDIC (€2) is trading above our estimate of fair value (€1.85)

Significantly Below Fair Value: MEDIC is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: MEDIC is good value based on its PE Ratio (21.8x) compared to the Medical Equipment industry average (38.6x).

PE vs Market: MEDIC is poor value based on its PE Ratio (21.8x) compared to the Greek market (13x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MEDIC's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: MEDIC is good value based on its PB Ratio (0.9x) compared to the XE Medical Equipment industry average (3.8x).

Next Steps

Future Growth

How is Medicon Hellas forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicon Hellas has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Next Steps

Past Performance

How has Medicon Hellas performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MEDIC has high quality earnings.

Growing Profit Margin: MEDIC's current net profit margins (3%) are lower than last year (24.7%).

Past Earnings Growth Analysis

Earnings Trend: MEDIC's earnings have grown by 15.7% per year over the past 5 years.

Accelerating Growth: MEDIC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MEDIC had negative earnings growth (-87.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.7%).

Return on Equity

High ROE: MEDIC's Return on Equity (4.1%) is considered low.

Next Steps

Financial Health

How is Medicon Hellas's financial position?

Financial Position Analysis

Short Term Liabilities: MEDIC's short term assets (€17.9M) exceed its short term liabilities (€3.1M).

Long Term Liabilities: MEDIC's short term assets (€17.9M) exceed its long term liabilities (€15.2M).

Debt to Equity History and Analysis

Debt Level: MEDIC's debt to equity ratio (127.2%) is considered high.

Reducing Debt: MEDIC's debt to equity ratio has reduced from 794.5% to 127.2% over the past 5 years.

Debt Coverage: MEDIC's debt is not well covered by operating cash flow (19.4%).

Interest Coverage: MEDIC earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Next Steps


What is Medicon Hellas's current dividend yield, its reliability and sustainability?

Dividend Yield vs Market

Notable Dividend: Unable to evaluate MEDIC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MEDIC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MEDIC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MEDIC's dividend payments have been increasing.

Current Payout to Shareholders

Dividend Coverage: MEDIC is not paying a notable dividend for the Greek market.

Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MEDIC's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Maria Dimotsantou Sotiriou (66yo)

no data


Ms. Maria Dimotsantou Sotiriou has been the Chairman of the Board and Chief Executive Officer of Medicon Hellas S.A. since October 31, 2014. Ms. Dimotsantou Sotiriou speaks English. 


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Medicon Hellas S.A.'s company bio, employee growth, exchange listings and data sources

Key Information

  • Name: Medicon Hellas S.A.
  • Ticker: MEDIC
  • Exchange: ATSE
  • Founded: 1978
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €8.839m
  • Shares outstanding: 4.42m
  • Website:


  • Medicon Hellas S.A.
  • Melitona 5-7
  • Gerakas
  • 153 44
  • Greece


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MEDICATSE (The Athens Stock Exchange)YesOrdinary SharesGREURJul 2001
0OKELSE (London Stock Exchange)YesOrdinary SharesGBEURJul 2001


Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company imports and distributes analytical workstations for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems under the MLR name. It also produces instrument-specific and barcoded vial reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry comprising control and calibration, and test. In addition, the company engages in the production of cosmetic and skin care products under the Miss Beaute brand name. Further, it develops and sells software for laboratory and medical applications; supplies IT systems to healthcare providers; and produces monoclonal and polyclonal antibodies as raw materials. Additionally, the company remanufactures and resells chemistry, hematology, blood gas, and immunochemistry analyzers; and provides contract remanufacturing and diagnostics laboratory services. It sells its products through supermarket chains and sales outlets. Medicon Hellas S.A. was founded in 1978 and is headquartered in Gerakas, Greece. 

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/05/26 14:42
End of Day Share Price2020/05/25 00:00
Annual Earnings2018/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.